[ET Net News Agency, 15 August 2019] Hua Medicine (02552) said its loss and total
comprehensive expense attributable to owners of the company was RMB235.5 million for the
six months ended 30 June 2019, compared to the loss of RMB1.51 billion of the same period
last year. The loss per share was RMB0.25. No dividend will be distributed.
The other income was RMB3.38 million, a year-on-year decrease of 50.51%. (RC)